Brief: Seikagaku signs agreement for license of lumbar disc herniation treatment agent with Ferring Pharmaceuticals
15/06/2016 09:12
June 15 (Reuters) - Seikagaku 4548.T :
* Says it signed an agreement for overseas exclusive sale
license of lumbar disc herniation treatment agent with Ferring
Pharmaceuticals
Source text in Japanese: http://985.so/3cwr
Further company coverage: 4548.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com;)(+86 010
62674724;)(Reuters
Messaging:)(shuai.liu.reuters.com@reuters.net))